Skip to main content

Table 2 Interleukin 17 levels in pleural effusion of lung cancer patients a

From: Elevated pleural effusion IL-17 is a diagnostic marker and outcome predictor in lung cancer patients

Clinical variables

Patients ( n)

IL-17 (pg/ml) Mean ± SD

P-value

Age (years)

  

0.343

  ≥60

38

27.08 ± 4.87

 

  <60

40

19.92 ± 5.28

 

Gender

  

0.259

  Male

36

21.23 ± 5.30

 

  Female

42

19.87 ± 5.23

 

Histologic type

  

0.491

  Adenocarcinoma

67

20.33 ± 6.12

 

  Nonadenocarcinoma

11

21.52 ± 5.05

 

ECOG PS

  

0.256

  0 or 1

50

19.99 ± 5.37

 

  2 to 4

28

21.41 ± 5.21

 

Cytologic examination

  

0.912

  Positive

60

20.46 ± 5.18

 

  Negative

18

20.62 ± 6.12

 

Stage

  

0.706

  M1a

54

20.34 ± 4.58

 

  M1b

24

20.83 ± 6.01

 

Location

  

0.751

  Right

50

20.34 ± 5.36

 

  Left

28

20.15 ± 4.97

 
  1. aECOG PS, Eastern Cooperative Oncology Group performance status; IL-17, Interleukin 17.